Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
09/21/2011 | EP1798222B1 Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery |
09/21/2011 | CN102197037A Morphinan compounds |
09/21/2011 | CN102197031A Substituted 5-aminopyrazoles and use thereof |
09/21/2011 | CN102196809A Agent for treatment of diabetic nephropathy |
09/21/2011 | CN102190673A Rare earth/ionic liquid luminescent material |
09/21/2011 | CN102190660A N-F Troger type quaternary ammonium salt and preparation method thereof |
09/21/2011 | CN102190658A Structural analogue of antineoplastic marine natural product ecteinascidins |
09/21/2011 | CN102190657A Process for preparing moxifloxacin and salts thereof |
09/21/2011 | CN102190638A Biaryl alcohol diamine compound, its pharmaceutical composition, preparation method and application |
09/21/2011 | CN101597289B 2-tryptophanyl-Beta-tetrahydric carboline-3-formyol amino-acid benzyl ester and preparation method and application thereof |
09/21/2011 | CN101268074B 5-amino-4-hydroxy-7- (imidazo [1,2-A] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
09/20/2011 | US8022214 N,N-disubstituted perylene-3,4:9,10-bis(dicarboximides), used as n-type junctions, integrated in various device designs including, circuits, thin film transistors, light-emitting diodes, photoelectric cells, detectors and capacitors |
09/20/2011 | US8022207 Compound having affinity to amyloid |
09/20/2011 | US8022206 Furo[3,2-C]pyridines |
09/20/2011 | US8022077 Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof |
09/20/2011 | US8022075 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
09/20/2011 | US8022065 Purine derivatives as kinase inhibitors |
09/20/2011 | US8022057 MAPK/ERK kinase inhibitors |
09/20/2011 | US8022047 Combination anticancer agents |
09/20/2011 | CA2617957C Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
09/20/2011 | CA2583737C Compounds and compositions as protein kinase inhibitors |
09/20/2011 | CA2516934C Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
09/20/2011 | CA2476067C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
09/15/2011 | WO2011112995A1 Imidazopyridines syk inhibitors |
09/15/2011 | WO2011112816A1 Oral formulations and lipophilic salts of methylnaltrexone |
09/15/2011 | WO2011112769A1 Compounds for the treatment of hepatitis c |
09/15/2011 | WO2011112731A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
09/15/2011 | WO2011112186A1 Compounds for the treatment of hepatitis c |
09/15/2011 | WO2011111875A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
09/15/2011 | WO2011110954A1 Highly pure varenicline or a pharmaceutically acceptable salt thereof substantially free of methylvarenicline impurity |
09/15/2011 | WO2011110479A1 Process for the manufacture of 5-halogenated-7-azaindoles |
09/15/2011 | WO2011110183A1 Azaisoquinolinone derivatives as nk3 antagonists |
09/15/2011 | WO2011109932A1 Novel process for the manufacture of 5-halogenated-7-azaindoles |
09/15/2011 | WO2011041989A3 Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems |
09/15/2011 | US20110224439 Process for Manufacturing 5-Chloromethyl-2,3-Pyridine Dicarboxylic Acid Anhydrides |
09/15/2011 | US20110224438 Novel process for the manufacture of 5-halogenated-7-azaindoles |
09/15/2011 | US20110224437 Process for preparing varenicline, varenicline intermediates, and pharmaceutically acceptable salts thereof |
09/15/2011 | US20110224403 Method of making a cyclic guanidine from dicyandiamide and coating compositions containing same |
09/15/2011 | US20110224250 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
09/15/2011 | US20110224249 Novel Hydrate Form |
09/15/2011 | US20110224248 Azaquinolones that inhibit prolyl hydroxylase |
09/15/2011 | US20110224247 Azaisoquinolinone derivatives as nk3 antagonists |
09/15/2011 | US20110224231 Novel Lactams as Beta Secretase Inhibitors |
09/15/2011 | US20110224199 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues |
09/15/2011 | US20110224197 Pyrimidines and pyridines useful as inhibitors of protein kinases |
09/15/2011 | US20110224195 Heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
09/15/2011 | US20110224191 Substituted Pyrrolo[2,3-b]-Pyridines and -Pyrazines |
09/15/2011 | US20110224190 Piperidin-4-yl azetidine derivatives as jak1 inhibitors |
09/15/2011 | US20110224187 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
09/15/2011 | US20110224155 Modulation of chemosensory receptors and ligands associated therewith |
09/15/2011 | US20110224079 Spiroheterocyclic n-oxyamides as pesticides |
09/15/2011 | US20110223132 Isothiazoloquinolones and related compounds as anti-infective agents |
09/15/2011 | US20110220884 Compound for organic thin-film transistor and organic thin-film transistor using same |
09/15/2011 | CA2792769A1 Imidazopyridines syk inhibitors |
09/15/2011 | CA2792539A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
09/15/2011 | CA2791460A1 Highly pure varenicline or a pharmaceutically acceptable salt thereof substantially free of methylvarenicline impurity |
09/14/2011 | EP2365735A2 Luminescent element material and luminescent element comprising the same |
09/14/2011 | EP2364983A2 Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same |
09/14/2011 | EP2364982A1 Spiro-piperidine compounds as chemokine receptor antagonists and medicinal use thereof |
09/14/2011 | EP2364981A1 Salts and crystalline forms of 2-methyl-2-[4- (3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile |
09/14/2011 | EP2364976A1 S1P receptor modulating compounds and use thereof |
09/14/2011 | EP2364970A1 Processes and intermediates |
09/14/2011 | EP2364705A2 Modulators of muscarinic receptors |
09/14/2011 | EP2364313A1 Aza-benzimidazolone chymase inhibitors |
09/14/2011 | EP2364311A1 Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betahsd1 |
09/14/2011 | EP2364308A1 Pyrazine compounds as phosphodiesterase 10 inhibitors |
09/14/2011 | EP2364306A1 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors |
09/14/2011 | EP2364301A1 Enantiomerically enriched aryloazol- 2 -yl cyanoethylamino paraciticidal compounds |
09/14/2011 | EP2364298A1 Quinolone compound and pharmaceutical composition |
09/14/2011 | EP2235017B1 Spiroindolinone derivatives as anticancer agents |
09/14/2011 | EP2229389B1 Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
09/14/2011 | EP2225241B1 Derivatives of N-phenyl-imidazo-(1,2-A)-pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
09/14/2011 | EP2164847B1 3-aza-bicyclo[3.3.0]octane compounds |
09/14/2011 | EP2139892B1 Substituted pyrimidodiazepines useful as plk1 inhibitors |
09/14/2011 | EP1896421B1 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met |
09/14/2011 | EP1874769B1 Novel aza- heterocycles serving as kinase inhibitors |
09/14/2011 | EP1727820B1 Amine derivatives with tyrosinkinase inhibiting activity |
09/14/2011 | EP1689387B1 Bicyclic inhibitors of mek and methods of synthesis thereof |
09/14/2011 | EP1559716B1 Pyrazolonaphthyridine derivative |
09/14/2011 | EP1346982B1 Vla-4 inhibitors |
09/14/2011 | CN1642551B Inhibitors of histone deacetylase |
09/14/2011 | CN1612861B Ecl labels having improved non-specific binding properties, methods of using and kits containing the same |
09/14/2011 | CN102186851A Triazolopyridine compounds as pim kinase inhibitors |
09/14/2011 | CN102186850A Phenanthroindolizidine derivative and nfkb inhibitor containing same as active ingredient |
09/14/2011 | CN102186849A Phenanthroindolizidine compound and nf?b inhibitor containing same as active ingredient |
09/14/2011 | CN102183589A Method for detecting contents of dolasetron isomer and salt thereof |
09/14/2011 | CN102180878A Dolasetron isomer or salt thereof, preparation method for the Dolasetron isomer or salt thereof and application of the Dolasetron isomer or salt thereof |
09/14/2011 | CN102180877A Synthetic process of imidazo phenanthroline compound |
09/14/2011 | CN102180876A New preparation method for Tadalafei crystal form I |
09/14/2011 | CN102180875A Preparation method of triazolopyridine derivative |
09/14/2011 | CN102180874A Synthetic process method for azabicyclo medicinal intermediates |
09/14/2011 | CN102180873A Functional ionic liquid and preparation method thereof |
09/14/2011 | CN101597293B Method for preparing purrocoline derivatives by microwave reaction |
09/14/2011 | CN101541798B Process for production of mirtazapine |
09/14/2011 | CN101528745B Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes |
09/14/2011 | CN101450947B 7-(3-oximido-4-amido-4-alkyl-1-piperidine)quinoline carboxylic acid derivates and preparation method thereof |
09/14/2011 | CN101423517B Gamma-carbolines derivates as well as preparation method and application thereof |
09/14/2011 | CN101014601B Preparation of 9-hydroxy-3- (2-hydroxyethyl) -2-methyl-4h-pyrid0[1, 2-a] pyrimidin-4-one and crystals thereof |
09/13/2011 | US8017781 Azaindazoles useful as inhibitors of kinases |
09/13/2011 | US8017779 Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |